A new multiomic network inference pipeline, SYGNAL, integrates patient data with mechanistically accurate transcriptional regulatory networks to predict drug combinations with synergistic anti-proliferative effects on glioblastoma multiforme.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cels.2016.08.002 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!